title: Imatinib-resistant chronic myeloid leukemia (CML): Current concepts on pathogenesis and new emerging pharmacologic approaches.
abstract: Chronic myeloid leukemia (CML) is a stem cell disease, in which the BCR/ABL oncoprotein is considered essential for abnormal growth and accumulation of neoplastic cells. During the past 10 years, the BCR/ABL tyrosine kinase inhibitor imatinib (STI571) has successfully been introduced in the treatment of the disease. However, intrinsic as well as acquired resistance against the drug have been described and have been recognized as an emerging problem and challenge in clinical practice, and a key issue in CML research. Most of the respective concepts focus on imatinib-resistant mutants of BCR/ABL that are detectable in a high proportion of cases. However, other factors also contribute to resistance against imatinib, including the genetic background, the biologic features of CML stem cells, gene amplifications, silencing of tumor suppressor genes, and various pharmacologic aspects. In this article, the mechanisms of resistance against imatinib and other BCR/ABL tyrosine kinase inhibitors in CML are discussed together with strategies to overcome and to prevent resistance with available drugs or with novel antileukemic approaches.
authors.affiliation: Department of Internal Medicine I, Division of Hematology and Hemostaseology, Medical University of Vienna, Vienna, Austria.
authors.forename: Peter
authors.initials: P
authors.lastname: Valent
references.citation: Proc Natl Acad Sci U S A. 2006 Dec 19;103(51):19466-71
references.pmid: 17164333
references.citation: Blood. 2007 Jan 15;109(2):500-2
references.pmid: 16990603
references.citation: Stem Cells. 1998;16 Suppl 1:77-83; discussion 89
references.pmid: 11012149
references.citation: Leuk Lymphoma. 2004 Nov;45(11):2197-203
references.pmid: 15512807
references.citation: Br J Haematol. 2002 Oct;119(1):109-11
references.pmid: 12358910
references.citation: Proc Natl Acad Sci U S A. 2002 Aug 6;99(16):10700-5
references.pmid: 12149456
references.citation: Clin Cancer Res. 2002 May;8(5):935-42
references.pmid: 12006504
references.citation: Curr Treat Options Oncol. 2000 Apr;1(1):51-62
references.pmid: 12057061
references.citation: N Engl J Med. 2002 Aug 15;347(7):539-40
references.pmid: 12181416
references.citation: Oncology. 2005;69(5):363-71
references.pmid: 16319507
references.citation: Science. 1990 Mar 2;247(4946):1079-82
references.pmid: 2408149
references.citation: Science. 2001 Aug 3;293(5531):876-80
references.pmid: 11423618
references.citation: Int J Hematol. 2005 May;81(4):307-9
references.pmid: 15914360
references.citation: Br J Cancer. 2006 Jun 19;94(12):1765-9
references.pmid: 16721371
references.citation: Leukemia. 2007 May;21(5):926-35
references.pmid: 17330101
references.citation: J Clin Oncol. 2003 Nov 15;21(22):4256-8
references.pmid: 14615464
references.citation: Leukemia. 2005 Mar;19(3):435-41
references.pmid: 15674418
references.citation: Bone Marrow Transplant. 2007 Jul;40(1):83-4
references.pmid: 17450179
references.citation: Hematology. 2005 Oct;10(5):349-59
references.pmid: 16203604
references.citation: Mini Rev Med Chem. 2004 Mar;4(3):285-99
references.pmid: 15032675
references.citation: Cancer Genet Cytogenet. 2002 Oct 1;138(1):22-6
references.pmid: 12419580
references.citation: Ann Intern Med. 2006 Dec 19;145(12):913-23
references.pmid: 17179059
references.citation: Blood. 2005 Dec 1;106(12):3948-54
references.pmid: 16105974
references.citation: Br J Haematol. 2007 May;137(4):297-306
references.pmid: 17408402
references.citation: Blood. 2003 Jun 15;101(12):4701-7
references.pmid: 12576334
references.citation: Blood. 2007 Jan 1;109(1):306-14
references.pmid: 16954504
references.citation: N Engl J Med. 2006 Dec 7;355(23):2408-17
references.pmid: 17151364
references.citation: Blood. 2006 Jun 1;107(11):4532-9
references.pmid: 16469872
references.citation: Science. 2004 Jul 16;305(5682):399-401
references.pmid: 15256671
references.citation: Lancet. 2002 Feb 9;359(9305):487-91
references.pmid: 11853795
references.citation: Am J Hematol. 2007 Sep;82(9):849-51
references.pmid: 17563075
references.citation: Blood. 2000 Jun 1;95(11):3498-505
references.pmid: 10828035
references.citation: Haematologica. 2005 Apr;90(4):534-41
references.pmid: 15820950
references.citation: Cancer Cell. 2005 Feb;7(2):129-41
references.pmid: 15710326
references.citation: Cell. 2003 Mar 21;112(6):831-43
references.pmid: 12654249
references.citation: Leuk Lymphoma. 2006 Jan;47(1):1-7
references.pmid: 16321820
references.citation: Blood. 2007 Apr 15;109(8):3207-13
references.pmid: 17185463
references.citation: Nat Rev Cancer. 2007 Jun;7(6):441-53
references.pmid: 17522713
references.citation: Leukemia. 2004 Mar;18(3):401-8
references.pmid: 14724652
references.citation: Cancer Genet Cytogenet. 2005 Jun;159(2):164-7
references.pmid: 15899391
references.citation: Hematol Oncol Clin North Am. 2004 Jun;18(3):753-74, xii
references.pmid: 15271404
references.citation: Nature. 1973 Jun 1;243(5405):290-3
references.pmid: 4126434
references.citation: J Clin Oncol. 2006 Aug 20;24(24):4028-9
references.pmid: 16921058
references.citation: Semin Hematol. 2003 Apr;40(2 Suppl 2):80-2
references.pmid: 12783380
references.citation: Semin Hematol. 2003 Jan;40(1):79-86
references.pmid: 12563614
references.citation: Cancer Cell. 2002 Aug;2(2):117-25
references.pmid: 12204532
references.citation: J Clin Pharmacol. 2004 Feb;44(2):158-62
references.pmid: 14747424
references.citation: Blood. 2002 May 1;99(9):3472-5
references.pmid: 11964322
references.citation: N Engl J Med. 2002 Feb 28;346(9):645-52
references.pmid: 11870241
references.citation: Cancer Chemother Pharmacol. 2005 Oct;56(4):358-60
references.pmid: 15883819
references.citation: Nat Rev Cancer. 2005 Mar;5(3):172-83
references.pmid: 15719031
references.citation: Science. 1990 Feb 16;247(4944):824-30
references.pmid: 2406902
references.citation: Nature. 2005 Jun 30;435(7046):1267-70
references.pmid: 15988530
references.citation: Blood. 2007 Jan 15;109(2):497-9
references.pmid: 16990591
references.citation: Nat Rev Cancer. 2007 May;7(5):345-56
references.pmid: 17457302
references.citation: N Engl J Med. 1986 Jan 23;314(4):202-7
references.pmid: 3510388
references.citation: Blood. 2003 Jul 1;102(1):276-83
references.pmid: 12623848
references.citation: Haematologica. 2003 Mar;88(3):260-7
references.pmid: 12651263
references.citation: Nature. 1982 Dec 23;300(5894):765-7
references.pmid: 6960256
references.citation: Cell. 1993 Oct 8;75(1):175-85
references.pmid: 8402896
references.citation: Cancer. 2006 Mar 15;106(6):1306-15
references.pmid: 16463391
references.citation: Blood. 2002 Mar 15;99(6):1928-37
references.pmid: 11877262
references.citation: J Clin Oncol. 2005 Jun 20;23(18):4100-9
references.pmid: 15867198
references.citation: Leukemia. 2007 Mar;21(3):494-504
references.pmid: 17252012
references.citation: Blood. 2007 Mar 15;109(6):2303-9
references.pmid: 17138817
references.citation: Proc Natl Acad Sci U S A. 2006 Feb 21;103(8):2794-9
references.pmid: 16477019
references.citation: Leuk Lymphoma. 2004 Jul;45(7):1453-8
references.pmid: 15359647
references.citation: Blood. 2007 May 15;109(10):4143-50
references.pmid: 17264298
references.citation: Cancer Lett. 2007 Jun 28;251(2):323-9
references.pmid: 17240048
references.citation: Drug Metab Dispos. 2005 Oct;33(10):1503-12
references.pmid: 16006570
references.citation: Br J Cancer. 2003 Nov 17;89(10):1855-9
references.pmid: 14612892
references.citation: Clin Pharmacokinet. 2005;44(9):879-94
references.pmid: 16122278
references.citation: Semin Hematol. 2003 Apr;40(2 Suppl 2):4-10
references.pmid: 12783368
references.citation: J Exp Med. 2007 Mar 19;204(3):461-5
references.pmid: 17353369
references.citation: Exp Hematol. 2007 Apr;35(4 Suppl 1):144-54
references.pmid: 17379100
references.citation: Blood. 2003 Jun 15;101(12):5010-3
references.pmid: 12595307
references.citation: Cytotherapy. 2000;2(6):411-21
references.pmid: 12044221
references.citation: Cancer Genet Cytogenet. 2003 Jun;143(2):140-4
references.pmid: 12781448
references.citation: Blood. 2001 Feb 1;97(3):720-8
references.pmid: 11157490
references.citation: Leuk Lymphoma. 2007 May;48(5):1053-6
references.pmid: 17487757
references.citation: Blood. 2007 Apr 15;109(8):3496-9
references.pmid: 17192396
references.citation: Leukemia. 2006 Jun;20(6):1028-34
references.pmid: 16617318
references.citation: Lancet Oncol. 2003 Apr;4(4):198
references.pmid: 12681250
references.citation: Hematol Oncol Clin North Am. 2004 Jun;18(3):545-68, vii-viii
references.pmid: 15271392
references.citation: Lancet Oncol. 2005 Feb;6(2):128
references.pmid: 15683824
references.citation: Cancer Genet Cytogenet. 2007 Apr 15;174(2):111-5
references.pmid: 17452251
references.citation: Leukemia. 2002 Apr;16(4):549-58
references.pmid: 11960331
references.citation: Blood. 2003 Mar 15;101(6):2368-73
references.pmid: 12609962
references.citation: Cancer Chemother Pharmacol. 2004 Oct;54(4):290-4
references.pmid: 15138710
references.citation: Cancer Chemother Pharmacol. 2004 Feb;53(2):102-6
references.pmid: 14605865
references.citation: Blood. 2007 Jul 15;110(2):678-85
references.pmid: 17395781
references.citation: Blood. 2003 Jan 15;101(2):473-5
references.pmid: 12393385
references.citation: Blood. 1995 Oct 15;86(8):3118-22
references.pmid: 7579406
references.citation: Cell. 2005 Dec 29;123(7):1293-305
references.pmid: 16377569
references.citation: Trends Pharmacol Sci. 2006 Jan;27(1):17-24
references.pmid: 16337012
references.citation: Br J Haematol. 2005 Aug;130(3):373-81
references.pmid: 16042686
references.citation: Blood. 2002 Aug 1;100(3):1014-8
references.pmid: 12130516
references.citation: Cancer Res. 2005 Apr 1;65(7):2577-82
references.pmid: 15805252
references.citation: Leukemia. 2007 Jun;21(6):1267-75
references.pmid: 17519960
references.citation: J Natl Cancer Inst. 1990 Jul 4;82(13):1133-40
references.pmid: 1972761
references.citation: J Pharmacol Exp Ther. 2003 Mar;304(3):1085-92
references.pmid: 12604685
references.citation: J Natl Cancer Inst. 2007 May 2;99(9):680-93
references.pmid: 17470736
references.citation: Eur J Haematol. 2003 Apr;70(4):235-9
references.pmid: 12656747
references.citation: Leukemia. 2006 Apr;20(4):658-63
references.pmid: 16467863
references.citation: Proc Natl Acad Sci U S A. 2005 Feb 8;102(6):1992-7
references.pmid: 15677719
references.citation: Leukemia. 2006 Jun;20(6):1061-6
references.pmid: 16642048
references.citation: Leuk Lymphoma. 2007 Feb;48(2):295-301
references.pmid: 17325889
references.citation: Blood. 2000 Mar 1;95(5):1758-66
references.pmid: 10688835
references.citation: N Engl J Med. 2001 Apr 5;344(14):1038-42
references.pmid: 11287973
references.citation: Blood. 2004 Jun 1;103(11):4010-22
references.pmid: 14982876
references.citation: Cancer. 2003 Nov 1;98(9):1905-11
references.pmid: 14584073
references.citation: Leuk Lymphoma. 2004 Apr;45(4):695-8
references.pmid: 15160941
references.citation: Lancet. 1998 Oct 3;352(9134):1087-92
references.pmid: 9798583
references.citation: Blood. 2005 May 15;105(10):4021-7
references.pmid: 15665113
references.citation: Br J Haematol. 2007 Jun;137(5):461-7
references.pmid: 17459051
references.citation: Clin Pharmacol Ther. 2008 Feb;83(2):258-64
references.pmid: 17568400
references.citation: N Engl J Med. 2003 Mar 13;348(11):994-1004
references.pmid: 12637609
references.citation: Semin Hematol. 2007 Jan;44(1 Suppl 1):S15-24
references.pmid: 17292737
references.citation: Mol Cell Biol. 2006 Aug;26(16):6082-93
references.pmid: 16880519
references.citation: J Clin Invest. 1993 Oct;92(4):1925-39
references.pmid: 8408645
references.citation: Blood. 2007 Apr 15;109(8):3609-10
references.pmid: 17409347
references.citation: Cancer Cell. 2005 Nov;8(5):355-68
references.pmid: 16286244
references.citation: Cancer Chemother Pharmacol. 2004 Apr;53(4):313-23
references.pmid: 14658008
references.citation: Blood. 1998 Nov 1;92(9):3362-7
references.pmid: 9787174
references.citation: Clin Pharmacol Ther. 2004 Oct;76(4):323-9
references.pmid: 15470331
references.citation: Int J Hematol. 2006 May;83(4):294-300
references.pmid: 16757427
references.citation: Cell Cycle. 2004 Dec;3(12):1502-5
references.pmid: 15611623
references.citation: Cancer. 2007 Jul 15;110(2):340-4
references.pmid: 17559140
references.citation: Oncogene. 2001 Sep 13;20(41):5826-35
references.pmid: 11593388
references.citation: Blood. 2000 Mar 15;95(6):2118-25
references.pmid: 10706883
references.citation: Blood. 2002 May 15;99(10):3530-9
references.pmid: 11986204
references.citation: Blood. 2004 Jan 15;103(2):451-5
references.pmid: 14512312
references.citation: Leukemia. 2006 Jun;20(6):1047-54
references.pmid: 16598311
references.citation: Cell Cycle. 2006 Dec;5(24):2862-6
references.pmid: 17172863
references.citation: Clin Cancer Res. 2005 Jun 15;11(12):4460-8
references.pmid: 15958631
references.citation: Br J Haematol. 2002 Oct;119(1):106-8
references.pmid: 12358909
references.citation: Mol Pharmacol. 2007 Sep;72(3):788-95
references.pmid: 17595328
references.citation: Blood. 2003 May 15;101(10):3794-800
references.pmid: 12560227
references.citation: Leukemia. 2004 Aug;18(8):1340-6
references.pmid: 15190256
references.citation: Blood. 2007 Oct 15;110(8):2991-5
references.pmid: 17625066
references.citation: Leukemia. 2006 Oct;20(10):1767-73
references.pmid: 16855631
references.citation: EMBO J. 1994 Feb 15;13(4):764-73
references.pmid: 8112292
references.citation: Nat Med. 2006 Oct;12(10):1181-4
references.pmid: 17013383
references.citation: Cancer Res. 2005 Jun 1;65(11):4500-5
references.pmid: 15930265
references.citation: Cancer Genet Cytogenet. 2000 May;119(1):8-14
references.pmid: 10812164
references.citation: EMBO J. 1997 Oct 15;16(20):6151-61
references.pmid: 9321394
references.citation: Ann Hematol. 2004 Jun;83(6):401-2
references.pmid: 14673623
references.citation: Cancer Genet Cytogenet. 2002 Nov;139(1):30-3
references.pmid: 12547154
references.citation: Blood. 2002 Jan 1;99(1):319-25
references.pmid: 11756187
references.citation: Oncogene. 2005 May 5;24(20):3246-56
references.pmid: 15735695
references.citation: N Engl J Med. 2003 Oct 9;349(15):1423-32
references.pmid: 14534335
references.citation: Ann Hematol. 2003 May;82(5):284-9
references.pmid: 12692682
references.citation: N Engl J Med. 2006 Jun 15;354(24):2531-41
references.pmid: 16775234
references.citation: Leuk Lymphoma. 2004 Aug;45(8):1623-6
references.pmid: 15370215
references.citation: Cancer Res. 2007 Jun 1;67(11):5300-7
references.pmid: 17545610
references.citation: Blood. 2004 Dec 1;104(12):3739-45
references.pmid: 15315971
references.citation: Eur J Clin Invest. 2007 Oct;37(10):808-13
references.pmid: 17727673
references.citation: N Engl J Med. 2001 Apr 5;344(14):1031-7
references.pmid: 11287972
references.citation: Leukemia. 2002 Nov;16(11):2190-6
references.pmid: 12399961
references.citation: Blood. 2002 May 15;99(10):3547-53
references.pmid: 11986206
references.citation: Cancer Genet Cytogenet. 2006 Oct 1;170(1):16-23
references.pmid: 16965950
references.citation: N Engl J Med. 1994 Oct 20;331(16):1063-7
references.pmid: 8090167
references.citation: Hematol Oncol. 2004 Dec;22(4):179-81
references.pmid: 15995975
references.citation: Leuk Lymphoma. 1993;11 Suppl 1:245-53
references.pmid: 8251904
references.citation: J Clin Oncol. 2004 Mar 1;22(5):935-42
references.pmid: 14990650
references.citation: Blood. 2007 Mar 1;109(5):2112-20
references.pmid: 17068153
references.citation: N Engl J Med. 2006 Jun 15;354(24):2542-51
references.pmid: 16775235
references.citation: Blood. 2005 Mar 1;105(5):1862-6
references.pmid: 15528314
references.citation: Cancer Biol Ther. 2005 Jul;4(7):747-52
references.pmid: 15970668
references.citation: Leukemia. 2002 Aug;16(8):1402-11
references.pmid: 12145676
references.citation: Science. 1992 May 8;256(5058):836-9
references.pmid: 1375394
references.citation: Proc Natl Acad Sci U S A. 2005 Aug 2;102(31):11011-6
references.pmid: 16046538
references.citation: Acta Haematol. 2006;115(1-2):109-12
references.pmid: 16424660
references.citation: Leuk Res. 2006 Dec;30(12):1577-9
references.pmid: 16630657
references.citation: Blood. 2006 Sep 15;108(6):1809-20
references.pmid: 16709930
references.citation: Blood. 2007 Jan 1;109(1):58-60
references.pmid: 16973963
references.citation: Semin Hematol. 2007 Jan;44(1 Suppl 1):S25-31
references.pmid: 17292738
references.citation: Blood. 2006 Aug 15;108(4):1421-3
references.pmid: 16601247